Trials / Completed
CompletedNCT05131061
68Ga-Pentixafor PET/CT for the Subtyping Diagnosis of Primary Aldosteronism
68Ga-Pentixafor PET/CT for the Subtyping Diagnosis of Primary Aldosteronism: A Prospective Diagnostic Accuracy Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Qifu Li · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- —
Summary
To evaluate the value of 68Ga-Pentixafor PET/CT in the diagnosis of primary aldosteronism subtype
Detailed description
This is a prospective study. We will enroll 100 patients with definite diagnosis of PA using adrenal venous sampling(AVS) as the gold standard for subtype to evaluate the value of 68Ga-pentixaforPET/CT in the diagnosis of PA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | 68Ga-Pentixafor PET/CT imaging | 68Ga-Pentixafor PET/CT imaging |
Timeline
- Start date
- 2021-11-11
- Primary completion
- 2022-05-01
- Completion
- 2022-05-31
- First posted
- 2021-11-23
- Last updated
- 2022-07-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05131061. Inclusion in this directory is not an endorsement.